Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) traded up 27.6% during trading on Thursday . The company traded as high as GBX 1,888 ($25.56) and last traded at GBX 1,773 ($24.00). 3,584,157 shares were traded during mid-day trading, an increase of 31% from the average session volume of 2,745,484 shares. The stock had previously closed at GBX 1,389 ($18.80).
Johnson Matthey Price Performance
The stock has a market cap of £2.89 billion, a P/E ratio of 29.40, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The business’s fifty day moving average price is GBX 1,307.66 and its 200 day moving average price is GBX 1,377.54.
Johnson Matthey (LON:JMAT – Get Free Report) last posted its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Sell-side analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
Insider Transactions at Johnson Matthey
In related news, insider Liam Condon bought 27 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was purchased at an average price of GBX 1,445 ($19.56) per share, with a total value of £390.15 ($528.16). Over the last 90 days, insiders purchased 75 shares of company stock valued at $99,927. 0.61% of the stock is currently owned by insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- Overbought Stocks Explained: Should You Trade Them?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- How to invest in marijuana stocks in 7 steps
- 3 Trades Members of Congress Are Making Right Now
- Market Cap Calculator: How to Calculate Market Cap
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.